US Stock MarketDetailed Quotes

Aura Biosciences (AURA)

Watchlist
  • 7.010
  • -0.040-0.57%
Close May 1 16:00 ET
  • 7.010
  • 0.0000.00%
Post 16:10 ET
450.04MMarket Cap-3.98P/E (TTM)

Aura Biosciences (AURA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
17.35%112.79M
-2.05%27.24M
20.12%27.91M
25.71%28.61M
30.13%29.04M
13.09%96.12M
12.20%27.81M
13.39%23.23M
12.26%22.76M
14.76%22.31M
Selling and administrative expenses
-1.42%22.49M
-2.43%5.34M
-7.55%5.73M
-2.58%5.73M
8.19%5.69M
15.46%22.81M
21.54%5.47M
22.45%6.2M
14.10%5.88M
4.41%5.26M
-General and administrative expense
-1.42%22.49M
-2.43%5.34M
-7.55%5.73M
-2.58%5.73M
8.19%5.69M
15.46%22.81M
21.54%5.47M
22.45%6.2M
14.10%5.88M
4.41%5.26M
Research and development costs
23.19%90.3M
-1.96%21.9M
30.18%22.18M
35.56%22.88M
36.89%23.34M
12.37%73.3M
10.13%22.33M
10.42%17.04M
11.63%16.88M
18.38%17.05M
Operating profit
-17.35%-112.79M
2.05%-27.24M
-20.12%-27.91M
-25.71%-28.61M
-30.13%-29.04M
-13.09%-96.12M
-12.20%-27.81M
-13.39%-23.23M
-12.26%-22.76M
-14.76%-22.31M
Net non-operating interest income expense
-29.67%6.63M
-24.09%1.54M
-19.62%1.82M
-31.54%1.68M
-40.63%1.59M
9.79%9.43M
-21.98%2.03M
13.98%2.26M
22.00%2.45M
34.86%2.69M
Non-operating interest income
-29.67%6.63M
-24.09%1.54M
-19.62%1.82M
-31.54%1.68M
-40.63%1.59M
9.79%9.43M
-21.98%2.03M
13.98%2.26M
22.00%2.45M
34.86%2.69M
Other net income (expense)
164.17%77K
502.70%149K
48.00%-13K
-38.46%-36K
25.00%-24K
-190.91%-120K
-120.33%-37K
-400.00%-25K
18.75%-26K
-146.15%-32K
Special income (charges)
----
----
----
----
----
--0
----
----
----
----
-Gain on sale of property,plant,equipment
----
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
164.17%77K
502.70%149K
48.00%-13K
-38.46%-36K
25.00%-24K
-57.89%-120K
-42.31%-37K
-400.00%-25K
18.75%-26K
-146.15%-32K
Income before tax
-22.21%-106.08M
1.03%-25.54M
-24.31%-26.1M
-32.62%-26.97M
-39.70%-27.47M
-13.81%-86.81M
-17.35%-25.81M
-13.43%-21M
-11.14%-20.34M
-12.56%-19.66M
Income tax
-3.57%108K
-37.50%15K
-39.53%26K
48K
-60.87%18K
-18.25%112K
-82.48%24K
43K
0
46K
Net income
-22.17%-106.19M
1.06%-25.56M
-24.18%-26.13M
-32.86%-27.02M
-39.47%-27.48M
-13.76%-86.92M
-16.73%-25.83M
-13.67%-21.04M
-11.14%-20.34M
-12.82%-19.71M
Net income continuous Operations
-22.17%-106.19M
1.06%-25.56M
-24.18%-26.13M
-32.86%-27.02M
-39.47%-27.48M
-13.76%-86.92M
-16.73%-25.83M
-13.67%-21.04M
-11.14%-20.34M
-12.82%-19.71M
Minority interest income
Net income attributable to the parent company
-22.17%-106.19M
1.06%-25.56M
-24.18%-26.13M
-32.86%-27.02M
-39.47%-27.48M
-13.76%-86.92M
-16.73%-25.83M
-13.67%-21.04M
-11.14%-20.34M
-12.82%-19.71M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-22.17%-106.19M
1.06%-25.56M
-24.18%-26.13M
-32.86%-27.02M
-39.47%-27.48M
-13.76%-86.92M
-16.73%-25.83M
-13.67%-21.04M
-11.14%-20.34M
-12.82%-19.71M
Basic earnings per share
-0.57%-1.76
28.85%-0.37
4.76%-0.4
-14.63%-0.47
-37.50%-0.55
9.33%-1.75
-4.00%-0.52
12.50%-0.42
14.58%-0.41
13.04%-0.4
Diluted earnings per share
-0.57%-1.76
28.85%-0.37
4.76%-0.4
-14.63%-0.47
-37.50%-0.55
9.33%-1.75
-4.00%-0.52
12.50%-0.42
14.58%-0.41
13.04%-0.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 17.35%112.79M-2.05%27.24M20.12%27.91M25.71%28.61M30.13%29.04M13.09%96.12M12.20%27.81M13.39%23.23M12.26%22.76M14.76%22.31M
Selling and administrative expenses -1.42%22.49M-2.43%5.34M-7.55%5.73M-2.58%5.73M8.19%5.69M15.46%22.81M21.54%5.47M22.45%6.2M14.10%5.88M4.41%5.26M
-General and administrative expense -1.42%22.49M-2.43%5.34M-7.55%5.73M-2.58%5.73M8.19%5.69M15.46%22.81M21.54%5.47M22.45%6.2M14.10%5.88M4.41%5.26M
Research and development costs 23.19%90.3M-1.96%21.9M30.18%22.18M35.56%22.88M36.89%23.34M12.37%73.3M10.13%22.33M10.42%17.04M11.63%16.88M18.38%17.05M
Operating profit -17.35%-112.79M2.05%-27.24M-20.12%-27.91M-25.71%-28.61M-30.13%-29.04M-13.09%-96.12M-12.20%-27.81M-13.39%-23.23M-12.26%-22.76M-14.76%-22.31M
Net non-operating interest income expense -29.67%6.63M-24.09%1.54M-19.62%1.82M-31.54%1.68M-40.63%1.59M9.79%9.43M-21.98%2.03M13.98%2.26M22.00%2.45M34.86%2.69M
Non-operating interest income -29.67%6.63M-24.09%1.54M-19.62%1.82M-31.54%1.68M-40.63%1.59M9.79%9.43M-21.98%2.03M13.98%2.26M22.00%2.45M34.86%2.69M
Other net income (expense) 164.17%77K502.70%149K48.00%-13K-38.46%-36K25.00%-24K-190.91%-120K-120.33%-37K-400.00%-25K18.75%-26K-146.15%-32K
Special income (charges) ----------------------0----------------
-Gain on sale of property,plant,equipment ----------------------0----------------
Other non- operating income (expenses) 164.17%77K502.70%149K48.00%-13K-38.46%-36K25.00%-24K-57.89%-120K-42.31%-37K-400.00%-25K18.75%-26K-146.15%-32K
Income before tax -22.21%-106.08M1.03%-25.54M-24.31%-26.1M-32.62%-26.97M-39.70%-27.47M-13.81%-86.81M-17.35%-25.81M-13.43%-21M-11.14%-20.34M-12.56%-19.66M
Income tax -3.57%108K-37.50%15K-39.53%26K48K-60.87%18K-18.25%112K-82.48%24K43K046K
Net income -22.17%-106.19M1.06%-25.56M-24.18%-26.13M-32.86%-27.02M-39.47%-27.48M-13.76%-86.92M-16.73%-25.83M-13.67%-21.04M-11.14%-20.34M-12.82%-19.71M
Net income continuous Operations -22.17%-106.19M1.06%-25.56M-24.18%-26.13M-32.86%-27.02M-39.47%-27.48M-13.76%-86.92M-16.73%-25.83M-13.67%-21.04M-11.14%-20.34M-12.82%-19.71M
Minority interest income
Net income attributable to the parent company -22.17%-106.19M1.06%-25.56M-24.18%-26.13M-32.86%-27.02M-39.47%-27.48M-13.76%-86.92M-16.73%-25.83M-13.67%-21.04M-11.14%-20.34M-12.82%-19.71M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -22.17%-106.19M1.06%-25.56M-24.18%-26.13M-32.86%-27.02M-39.47%-27.48M-13.76%-86.92M-16.73%-25.83M-13.67%-21.04M-11.14%-20.34M-12.82%-19.71M
Basic earnings per share -0.57%-1.7628.85%-0.374.76%-0.4-14.63%-0.47-37.50%-0.559.33%-1.75-4.00%-0.5212.50%-0.4214.58%-0.4113.04%-0.4
Diluted earnings per share -0.57%-1.7628.85%-0.374.76%-0.4-14.63%-0.47-37.50%-0.559.33%-1.75-4.00%-0.5212.50%-0.4214.58%-0.4113.04%-0.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More